HKEX: 2273 - Gushengtang Holdings Limited

Yield per half year: -21.52%
Sector: Healthcare

Gushengtang Holdings Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
46.88 35.42 32.36% 28.35 +65.33%
P/S 5.09 7.59 -32.94%
P/BV 4.66 3.68 26.51%
P/FCF 33.09 55.3 -40.15%
Ev/Ebitda 31.58 2.91 986.01%
Ev/S 4.85 23.72 -79.54%
Ev/FCF 30.89 63.78 -51.57%
E/P 0.0208 0.0326 -36.26%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
11.21 -11.9 -194.19% 0 0%
ROE 11.26 5.19 117.12%
ROA 7.55 3.47 117.58%
ROIC 0 0 0%
ROS 10.84 -11.49 -194.37%
ROCE 0 6.04 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
7/10
1.64 0.7755 111.88% 1.64 0%
Nеt Debt/Ebitda 0 0.0127 -100%
Debt/Ratio 0.1042 0.1229 -15.15%
Debt/Equity 1.06 0.802 32.02%
Debt/Net Income 1.54 1.76 -12.6%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
3.9/10
1.56 2.43 -35.82% 1.22 +28.16%
Number of years of dividend growth 0 1.21 -100%
DSI 0.8333 0.563 48.02%
Average dividend growth -107.69 3.2 -3462.29%
Average percentage for 5 years 1.22 1.82 -32.95%
Average percentage for payments 43.34 23.96 80.89%
Difference from average difference in sector -0.8705

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
158.88 28.69 453.78%
Growth impulse Ebitda in 5 years 0 -40.52 -100%
Growth impulse Net Income in 5 years -270.54 94.84 -385.26%
Growth impulse FCF in 5 years 188.51 91.41 106.22%
Growth impulse EPS in 5 years -153.68 -118.14 30.08%
IP Score
4.75/10

Similar companies

JD Health International Inc.

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co. Ltd.

Hangzhou Tigermed Consulting Co., Ltd

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription